- Report
- April 2025
- 384 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 378 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 74 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 183 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 154 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 307 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 178 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 66 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 72 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- March 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- April 2025
- 400 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 250 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 250 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 250 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more